GE HealthCare Q2 revenues up 9% organically; raises FY2023 guidance

GE HealthCare Technologies Inc.

2023-Q2 EPS reported $1.33 revenue$9,524,000,000

Revenue $4.8B, +7% reported, +9% organic; organic orders +6%.
Net income $418M ($0.91 EPS) vs $485M ($1.04) prior year; adjusted EPS $0.92 vs $1.15.
Imaging revenue +9% organic to $2.6B; Pharmaceutical Diagnostics +20% organic to $568M.
FY2023 guidance raised: organic revenue growth 6-8% (prior 5-7%); adjusted EPS $3.70-$3.85 (prior $3.60-$3.75).
Adjusted EBIT margin guidance 15.0%-15.5%, free cash flow conversion 85%+.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.97

GE HealthCare Technologies Inc. reported second quarter ended June 30, 2023 results: revenue $4.8 billion, net income $418 million, EPS $0.91. Guidance raised.

Period: second quarter ended June 30, 2023
Revenue: $4.8 billion
Net income: $418 million
EPS: $0.91
Guidance: raised
Result: reported results

Exact text from the filing

raising our top- and bottom-line guidance for the full year as we execute our precision care strategy. ” Second Quarter 2023 Total Company Financial Performance • Revenues of $4.8 billion increased 7% reported and 9% on an Organic basis* year-over-year. Foreign exchange negatively impacted growth by 2%. • Total company orders increased 6% organically, driven by

View on SEC.gov

Browse all earnings releases →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001932393-23-000111

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.